PTTEX
Price
$78.66
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
SLMCX
Price
$132.73
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
Ad is loading...

PTTEX vs SLMCX

Header iconPTTEX vs SLMCX Comparison
Open Charts PTTEX vs SLMCXBanner chart's image
Putnam Global Technology R6
Price$78.66
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Columbia Seligman Tech & Info A
Price$132.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PTTEX vs SLMCX Comparison Chart
Loading...
VS
PTTEX vs. SLMCX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTTEX is a Buy and SLMCX is a Buy.

FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 13.6B vs. PTTEX (1.36B). PTTEX pays higher dividends than SLMCX: PTTEX (0.58) vs SLMCX (0.00). PTTEX was incepted earlier than SLMCX: PTTEX (6 years) vs SLMCX (41 years). PTTEX is a more actively managed with annual turnover of: 57.00 vs. SLMCX (13.00). PTTEX has a lower initial minimum investment than SLMCX: PTTEX (0) vs SLMCX (2000). PTTEX annual gain was more profitable for investors over the last year : 47.68 vs. SLMCX (27.03). PTTEX return over 5 years is better than : 107.75 vs. SLMCX (70.82).
PTTEXSLMCXPTTEX / SLMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years41 years-
Gain YTD29.35418.721157%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.36B13.6B10%
Annual Yield % from dividends0.580.00-
Returns for 1 year47.6827.03176%
Returns for 3 years10.173.97256%
Returns for 5 years107.7570.82152%
Returns for 10 yearsN/A146.16-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RUNTX29.410.38
+1.31%
Russell Inv US Small Cap Equity M
SLVIX37.460.31
+0.83%
Columbia Select Large Cap Value Inst2
RRFDX38.520.28
+0.73%
T. Rowe Price Equity Income R
GFVAX16.73N/A
N/A
Goldman Sachs Focused Value A
NALFX69.57N/A
N/A
New Alternatives A